|
STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (USD $) In Thousands
|
Total
|
Common Stock [Member]
|
Additional Paid-in Capital [Member]
|
Accumulated Deficit during Development Stage [Member]
|
| Balance at Jun. 08, 2011 |
$ 0 |
$ 0 |
$ 0 |
$ 0 |
| Issuance of shares of common stock |
5,145 |
170 |
4,975 |
0 |
| Stock-based compensation |
474 |
|
474 |
0 |
| Net loss for the year |
(2,754) |
0 |
0 |
(2,754) |
| Balance at Dec. 31, 2011 |
2,865 |
170 |
5,449 |
(2,754) |
| Conversion of Series A Convertible Preferred stock, classified as mezzanine equity |
76 |
8 |
68 |
0 |
| Stock-based compensation |
8,087 |
3 |
8,084 |
0 |
| Recording of equity instruments upon Merger, net of fair value of issued warrants $21,954 and issuance cost of $463 (refer to Note 6) |
54,961 |
152 |
54,809 |
0 |
| Issuance of warrants (refer to Note 9) |
2,883 |
0 |
2,883 |
0 |
| Conversion of Series A Preferred Convertible Preferred stock, classified as equity |
0 |
201 |
(201) |
0 |
| Exercise of warrants |
22,932 |
76 |
22,856 |
0 |
| Exercise of stock options and vesting of Restricted Stock Units (“RSUs”) |
509 |
8 |
501 |
0 |
| Conversion of derivative warrants into equity warrants |
0 |
|
|
|
| Issuance of shares in connection with a financing round, net of issuance cost of $52 |
31,148 |
96 |
31,052 |
0 |
| Shares issued for acquisition of patents (refer to Note 5) |
750 |
2 |
748 |
0 |
| Issuance of shares in connection with a financing round, net of issuance cost of $39 |
44,962 |
103 |
44,859 |
0 |
| Net loss for the year |
(20,841) |
0 |
0 |
(20,841) |
| Balance at Dec. 31, 2012 |
148,332 |
819 |
171,108 |
(23,595) |
| Stock-based compensation |
12,093 |
0 |
12,093 |
0 |
| Exercise of warrants |
1,398 |
4 |
1,394 |
0 |
| Exercise of stock options and vesting of Restricted Stock Units (“RSUs”) |
974 |
22 |
952 |
0 |
| Conversion of derivative warrants into equity warrants |
3,918 |
0 |
3,918 |
0 |
| Net loss for the year |
(52,433) |
0 |
0 |
(52,433) |
| Balance at Dec. 31, 2013 |
$ 114,282 |
$ 845 |
$ 189,465 |
$ (76,028) |